Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does erythropoietin protect the preterm brain?

T Strunk1, C Härtel, C Schultz

  • 1Campus Lubeck, Department of Paediatrics, Ratzeburger Allee 160, 23538 Lubeck, Germany.

Archives of Disease in Childhood. Fetal and Neonatal Edition
|June 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly dynamic gamma-ray emissions are common in tropical thunderclouds.

Nature·2024
Same author

Flickering gamma-ray flashes, the missing link between gamma glows and TGFs.

Nature·2024
Same author

Moderate-intensity continuous training reduces triglyceridemia and improves oxygen consumption in dyslipidemic apoCIII transgenic mice.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2024
Same author

Effects of multistrain Bifidobacteria and Lactobacillus probiotics on HMO compositions after supplementation to pregnant women at threatening preterm delivery: design of the randomized clinical PROMO trial.

Molecular and cellular pediatrics·2024
Same author

Long-acting injectable progesterone treatment prior to puberty induction in gilts.

Domestic animal endocrinology·2023
Same author

First-Day-of-Life Rectal Swabs Fail To Represent Meconial Microbiota Composition and Underestimate the Presence of Antibiotic Resistance Genes.

Microbiology spectrum·2023

Recombinant human erythropoietin may improve neurodevelopmental outcomes for preterm infants with brain injury. This study investigates its potential to prevent or reduce harm from hypoxic-ischaemic injury.

Area of Science:

  • Neonatal neurology
  • Developmental neuroscience
  • Pharmacology

Background:

  • Hypoxic-ischaemic brain injury and intraventricular haemorrhage are common in preterm infants, leading to mortality and long-term disabilities.
  • Current interventions are insufficient to prevent infant brain injury or mitigate neurodevelopmental deficits.

Purpose of the Study:

  • To test the hypothesis that systemic administration of recombinant human erythropoietin (rhEPO) improves neurodevelopmental outcomes in high-risk preterm infants with brain injury.

Main Methods:

  • A multicentre, randomized, placebo-controlled study will prospectively evaluate the effects of rhEPO.

Main Results:

  • This section is to be filled upon study completion.

Related Experiment Videos

Conclusions:

  • Further research is needed to determine if rhEPO can be an effective therapeutic agent for preventing brain injury in preterm infants.